Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries’ wholly owned subsidiary has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for generic version of Coreg CR, (carvedilol phosphate) extended release capsules, 10mg, 20mg, 40mg, 80 mg.

These generic carvedilol phosphate extended release capsules, 10mg, 20mg, 40mg, 80mg are therapeutic equivalents of GSK’s Coreg CR extended release capsules. As per IMS, Coreg CR had annual sales of around $208 million in the US for the 12 months ended August 2017.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.